YLG-92064-08505
3 vaccinations
6 coded responses
27 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 787 / TX
- Registered
- 2021-03-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-22
Dose 1 — Pfizer-BioNTech
-
2021-03-23
Registered in v-safe
-
2021-03-23
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness, Euphoric mood, Feeling abnormal, Migraine, Photophobia — Feeling: Good · Site: Pain · Headache, Muscle or body achesFree text: Dizzy, very sensitive to bright lights yesterday, like a migraine but just super extra sensitive to light. Also felt euphoria and foggy yesterday after the shot.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Survey response — days 1–6 daily, dose 1MedDRA: Asthenia, Dizziness, Feeling abnormal, Photophobia — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Dizziness and sensitivity to light. Feeling low energy and mental fog.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-25
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, DiarrheaFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-27
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-03-28
- 2021-03-29
- 2021-04-06
-
2021-04-12
Dose 2 — Pfizer-BioNTech
-
2021-04-12
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-04-17
- 2021-04-18
- 2021-04-21
- 2021-04-26
- 2021-05-03
- 2021-05-10
-
2021-05-19
Survey response — day 35, dose 2MedDRA: Decreased appetite — Feeling: FairFree text: Loss of appetite for a few weeks nowMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-26
Survey response — day 42, dose 2MedDRA: Ageusia, Decreased appetite — Feeling: GoodFree text: Still have some loss of appetite and taste, noticing things with tons of flavor are the best.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-10-11
Survey response — 6 months, dose 2MedDRA: Chest pain, Weight decreased — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: More weight loss and also chest painMedDRA releases: 2024-11 · check-in free text available
-
2021-10-11
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-18
-
2021-12-03
Dose 3 — Pfizer-BioNTech
-
2021-12-04
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling · Headache, Muscle or body aches, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-12-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-12-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Muscle or body achesAdult check-in
- 2021-12-10
- 2021-12-17
- 2021-12-31
- 2022-01-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Pfizer-BioNTech | |
| 2 | 2021-04-12 | Pfizer-BioNTech | |
| 3 | 2021-12-03 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-11 | Unsuccessful |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Dizzy, very sensitive to bright lights yesterday, like a migraine but just super extra sensitive to light. Also felt euphoria and foggy yesterday after the shot.
Systemic reaction (other): Dizziness and sensitivity to light. Feeling low energy and mental fog.
Systemic reaction (other): Dizziness
Release 8 — day 35, dose 2
Symptoms: Loss of appetite for a few weeks now
Release 8 — day 42, dose 2
Symptoms: Still have some loss of appetite and taste, noticing things with tons of flavor are the best.
Release 10 — 6 months, dose 2
Symptoms: More weight loss and also chest pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | ✓ | ✓ | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Decreased appetite | ✓ | ✓ | ✓ |
| SD | Weight decreased | · | · | ✓ |
| SRO | Asthenia | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Euphoric mood | ✓ | ✓ | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Migraine | ✓ | ✓ | ✓ |
| SRO | Photophobia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release